What is the likely cause of anemia and appropriate treatment in a patient with elevated C‑reactive protein (CRP) and low total iron‑binding capacity (TIBC) of 247 µg/dL?

Anemia of Chronic Disease (ACD) with Functional Iron Deficiency

This patient most likely has anemia of chronic disease (ACD) with possible functional iron deficiency, given the elevated CRP (indicating inflammation) and low-normal TIBC of 247 µg/dL (normal range typically 250-450 µg/dL), and treatment should prioritize addressing the underlying inflammatory condition while considering intravenous iron supplementation over oral iron.

Understanding the Laboratory Pattern

The combination of elevated CRP and low TIBC is characteristic of inflammatory states. Low TIBC reflects the body's response to inflammation, where the liver produces less transferrin and more hepcidin, which blocks iron absorption and mobilization 1, 2. This creates a situation where iron may be present in the body but is sequestered and unavailable for erythropoiesis—termed "functional iron deficiency."

Key Diagnostic Considerations

To properly characterize this anemia, you need:

• Serum ferritin level: In inflammatory states, ferritin up to 100 µg/L may still represent iron deficiency because ferritin is an acute phase reactant 1, 2
• Transferrin saturation (TSAT): TSAT <20% suggests iron-restricted erythropoiesis 2
• Complete blood count with MCV and RDW: To distinguish between microcytic (iron deficiency), normocytic (ACD), or mixed patterns 1
• Reticulocyte count: Low/normal suggests inadequate bone marrow response; elevated suggests hemolysis or bleeding 1

A useful clinical tool: The ferritin/CRP ratio ≤6 predicts true iron deficiency even in the presence of inflammation (sensitivity and specificity >85%) 3. This simple calculation can help determine if iron supplementation is warranted.

Identifying the Underlying Cause

The elevated CRP demands investigation for:

• Inflammatory bowel disease (IBD): One-third of active IBD patients have iron deficiency 2
• Chronic kidney disease: Check creatinine and GFR; CKD is likely if GFR <60 mL/min/1.73m² 2
• Chronic heart failure: 40-70% have iron deficiency 2
• Malignancy: Particularly GI tract sources
• Chronic infections or autoimmune conditions

GI evaluation (upper and lower endoscopy) is warranted if absolute iron deficiency is confirmed, as occult bleeding may coexist with inflammatory conditions 2.

Treatment Algorithm

1. Address the Underlying Inflammatory Condition First

The primary driver of this anemia is inflammation. Treating the root cause (e.g., IBD flare, infection, malignancy) will improve both the anemia and iron utilization 1, 4.

2. Iron Supplementation Strategy

Intravenous iron is superior to oral iron in inflammatory states 2, 4:

• In IBD patients with elevated CRP, oral iron produces significantly lower hemoglobin responses (1.1 g/dL vs 2.0 g/dL increase at 2 weeks in high vs low CRP groups) 4
• Inflammation impairs oral iron absorption through hepcidin-mediated mechanisms 2
• For IBD specifically: oral iron should contain ≤100 mg elemental iron daily if used; IV iron is preferred for active disease 2

IV iron indications in this context:

• Intolerance to oral iron
• Inadequate response to oral iron after 4-6 weeks
• Active inflammation with CRP elevation
• Need for rapid correction
• Concurrent ESA therapy (if CKD present)

3. Monitoring Response

Patients with elevated CRP require higher doses of erythropoiesis-stimulating agents (ESAs) if CKD is present—CRP ≥3 mg/L predicts ESA hyporesponsiveness 5, 6. Even minor CRP elevations (3-10 mg/L) increase the risk of treatment resistance 6.

Recheck hemoglobin, iron studies, and CRP at 4-8 weeks after initiating therapy to assess response and adjust treatment 1, 2.

Critical Pitfalls to Avoid

1. Don't rely on ferritin alone in inflammatory states: Ferritin is falsely elevated by inflammation. Use TSAT and the ferritin/CRP ratio instead 1, 3

2. Don't assume normal TSAT excludes iron deficiency: Patients with normal TSAT but low serum iron (<70 µg/dL men, <60 µg/dL women) remain at risk for anemia 7

3. Don't use oral iron as first-line in active inflammation: It's poorly absorbed and less effective 2, 4

4. Don't forget to investigate for GI blood loss: Inflammation and bleeding often coexist, particularly in elderly patients on anticoagulants/antiplatelets 2

5. In CKD patients, interpret iron studies differently: Absolute iron deficiency is defined as TSAT ≤20% with ferritin ≤100 µg/L (predialysis) or ≤200 µg/L (hemodialysis) 2

Special Population Considerations

If this patient has CKD (GFR <30): Functional iron deficiency is common, and IV iron with possible ESA therapy should be managed by nephrology 2

If this patient has CHF: IV iron improves functional capacity and quality of life even with functional (not absolute) iron deficiency; oral iron should be avoided 2

If elderly with comorbidities: Weigh risks/benefits of invasive GI investigation, but don't withhold iron therapy 2